REVIEW OF THE ROLE OF PERIOSTIN AS A NOVEL BIOMARKER OF BRONCHIAL ASTHMA



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The survey shows the role of periostin in the asthma research. This is extracellular protein involved in the pathogenesis of chronic inflammation in asthma in children and adults. The role of periostin in the pathogenesis of atopic and nonatopic diseases was analyzed in this review. The appearance of the biomarker, responsible for airways remodeling, can give a clear understanding of the clinical stage of the process and the ability to achieve asthma control. Correlation between periostin, peripheral blood eosinophilia and fractional exhaled nitric oxide can be considered as an additional criterion for control of the disease.

Full Text

Restricted Access

About the authors

S S Masalskiy

Stavropol State Medical University

Email: masalsky@live.com

A S Kalmikova

Stavropol State Medical University

O P Ukhanova

Stavropol State Medical University

L Y Klimov

Stavropol State Medical University

A V Razgulaeva

Stavropol State Medical University

References

  1. ВОЗ, информационный бюллетень № 307, май 2011 г. http://www.who.int/mediacentre/factsheets/fs307/ru.
  2. Белая книга WAO по аллергии 2011-2012: резюме. На русском языке под ред. Р.И. Сепиашвили, ТА. Славянской. М., «Медицина-Здоровье». 2011, с. 6-8.
  3. Kong P., Christia P., Saxena A. et al. Lack of specificity of Fibroblast Specific Protein (FSP) 1 in cardiac remodeling and fibrosis. Am. J. Physiol. Heart Circ. Physiol. 2013, v. 9, p. 1363-1372.
  4. Bakhtyar N., Wong N., Kapoor A. et al. Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostin. Eur. J. Cancer. 2013, v. 16, p. 3537-3546.
  5. Bao S., Ouyang G., Bai X. et al. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell. 2004, v. 4, p. 329-339.
  6. Soltermann A. Epithelial-mesenchymal transition in nonsmall cell lung cancer. Pathologe. 2012, v. 2, p. 311-317.
  7. Мамаджанов З.К. Метастатический рак молочной железы (прогноз и результаты лечения). Автореферат диссертации канд. мед. наук. Бишкек, 2007, 122 c.
  8. Slany A., Haudek-Prinz V., Meshcheryakova A. et al. J. Extracellular matrix remodeling by bone marrow fibroblast-like cells correlates with disease progression in multiple myeloma. J. Proteome Res. 2013, v. 2, p. 844-854.
  9. Hamilton R.G., MacGlashan D.W., Saini S.S. IgE antibody-specific activity in human allergic disease. Immunol. Res. 2010, v. 47, p. 273-284.
  10. Hou J.J., Nie F.F., Li B.L. et al. The expressions of periostin and the related factors during healing process of full-thickness cutaneous wound in rat. Zhongguo Wei Zhong Bing JiJiu Yi Xue. 2012, v. 6, p. 334-337.
  11. Minicucci M.F., Santos P.P., Rafacho B.P. еt al. Periostin as a modulator of chronic cardiac remodeling after myocardial infarction. Clinics (Sao Paulo). 2013, v. 10, p. 1344-1349.
  12. Yamaguchi Y., Ono J., Masuoka M. et al. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. Br. J. Dermatol. 2013, v. 168, p. 717-725.
  13. Guerrot D., Dussaule J.C., Mael-Ainin M. et al. Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy. PLoS One. 2012, v. 7, doi: 10.1371.
  14. Morelli M., Misaggi R., Di Cello A. et al. Tissue expression and serum levels of periostin during pregnancy: a new biomarker of embryo-endometrial cross talk at implantation. Eur. J. Obstet. Gynecol. Reprod. Biol. 2014, v. 175, p. 140-144.
  15. Takayama G., Arima K., Kanaji T. et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. Japan J. Allergy Clin. Immunol. 2006, v. 118, p. 98-104.
  16. Клименко В.А., Криворотько Д.Н. Анализ выдыхаемого воздуха как маркер биохимических процессов в организме. Здоровье ребенка. 2011, № 1, с. 28.
  17. Мизерницкий Ю.Л., Цыпленкова С.Э. Мониторирование уровня оксида азота в выдыхаемом воздухе при неконтролируемой тяжелой бронхиальной астме на фоне анти-IgE-терапии. Сборник «Здоровье школьника». Под ред. А.Ф. Бабцевой, Е.Б. Романцовой. Благовещенск, 2012, с. 42.
  18. Malinovschi A., Pizzimenti S., Sciascia S. et al. Exhaled breath condensate nitrates, but not nitrites or FeNO, relate to asthma control. Respir Med. 2011, v. 105, p. 1007-1013.
  19. Kato G., Takahashi K., Izuhara K. et al. Markers that can reflect asthmatic activity before and after reduction of inhaled corticosteroids: a pilot study. Biomark Insights. 2013, v. 8, p. 97-105.
  20. Agrawal S., Townley R.G. Role of periostin, FeNO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma. Expert. Opin. Biol. Ther. 2014, v. 14, p. 165-181.
  21. Kato G., Takahashi K., Izuhara K. et al. Markers that can reflect asthmatic activity before and after reduction of inhaled corticosteroids: a pilot study. Biomark. Insights. 2013, v. 8, p. 97-105.
  22. Shoda T., Futamura K., Kobayashi F. et al. Cell type-dependent effects of corticosteroid on periostin production by primary human tissue cells. Allergy. 2013, v. 11, p. 1467-1470.
  23. Sasaki H., Sato Y., Kondo S. et al. Expression of the periostin mRNA level in neuroblastoma. J Pediatr Surg. 2002, v. 37, p. 1293-1297.
  24. Lindsley A., Li W., Wang J., Maeda N. et al. Comparison of the four mouse fasciclin-containing genes expression patterns during valvuloseptal morphogenesis. Gene Expr. Patterns. 2005, v. 5, p. 593-600.
  25. Osman L., Chester A.H., Sarathchandra P. et al. A novel role of the sympathoadrenergic system in regulating valve calcification. Circulation. 2007, v. 11, p. 116.
  26. Kashima T.G., Nishiyama T., Shimazu K. et al. Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions. Hum. Pathol. 2009, v. 2, p. 226-237.
  27. Lopez-Guisa J.M., Powers C., File D. et al. Airway epithelial cells from asthmatic children differentially express proremodeling factors. J. Allergy Clin. Immunol. 2012, v. 4, p. 990-997.
  28. Ando T., Xiao W., Gao P. et al. Critical role for mast cell Stat5 activity in skin inflammation. Cell. Rep. 2014, v. 2, p. 366-376.
  29. Hanania N.A., Wenzel S., Rosén K. et al. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study. Am. J. Respir. Crit. Care Med. 2013, v. 8, p. 804-811.
  30. Baek H., Jae-Won Oh., Ha-Baik Lee et al. Serum periostin levels correlate with bronchial hyper responsiveness to mannitol and methacholine in children with asthma. Journal of Allergy and Clinical Immunology. 2013, v. 2, p. 194.
  31. Hambly N., Nair P. Monoclonal antibodies for the treatment of refractory asthma. Curr. Opin. Pulm. Med. 2014, v. 20, p. 87-94.
  32. Bergquist P., Crompton G.K. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur. Respir. July. 2001, v. 1, p. 248.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2014



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies